Breast Mass in Young Woman with Strong Family History of Cancer

Case at a Glance

A 34-year-old woman of Ashkenazi Jewish descent presented with a small, hard, painless, fixed palpable breast mass located at the 3 o'clock position in the retroareolar region. Given her significant family history of breast and prostate cancers and her ethnic background predisposing to BRCA mutations, this case required careful evaluation and genetic counseling.

Patient's Story

The patient discovered a small breast lump during self-examination. The mass was described as hard, painless, and non-mobile. She had no associated symptoms such as nipple discharge, skin changes, or breast pain. Her menstrual history was unremarkable, and she had no previous history of breast problems or hormone replacement therapy.

Initial Assessment

Physical examination revealed a small, firm, fixed mass in the right breast at the 3 o'clock position, retroareolar region. The mass was approximately 1.5 cm in diameter, hard to palpation, and immobile. No skin changes, nipple retraction, or lymphadenopathy were noted. Given the patient's Ashkenazi Jewish heritage and strong family history, genetic predisposition was a significant concern.

The Diagnostic Journey

Bilateral mammography and targeted breast ultrasound were performed. The imaging studies revealed a hypoechoic mass with irregular borders and posterior acoustic shadowing on ultrasound. Mammography showed a corresponding density with spiculated margins. The radiologist initially considered a BI-RADS 4A classification pending further evaluation. Genetic testing for BRCA1 and BRCA2 mutations was initiated, with results pending at the time of initial evaluation.

Final Diagnosis

Core needle biopsy was recommended and performed under ultrasound guidance. Histopathological examination revealed invasive ductal carcinoma, grade 2, with negative hormone receptors. Genetic testing later confirmed a BRCA2 mutation, explaining the strong family history and early onset of disease.

Treatment Plan

Following multidisciplinary team discussion, the patient was offered several treatment options including breast-conserving surgery with sentinel lymph node biopsy versus mastectomy. Given her BRCA2 positive status and desire for risk reduction, she opted for bilateral mastectomy with immediate reconstruction. Adjuvant chemotherapy was planned based on final staging. Genetic counseling was provided for family screening recommendations.

Outcome and Follow-up

The patient underwent successful bilateral mastectomy with immediate tissue expander placement. Final pathology showed a 1.8 cm invasive ductal carcinoma, T1c N0 M0, with clear margins. She completed adjuvant chemotherapy without significant complications. At 12-month follow-up, she remained disease-free with good cosmetic results from reconstruction. Annual surveillance with MRI was planned, and family members were counseled regarding genetic testing.